An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. [PDF]
Wan L +11 more
europepmc +1 more source
Perioperative immunotherapy in gastric cancer: walking a fine line between hope and caution. [PDF]
Cai X, Xiao X, Zhang C, Yu W.
europepmc +1 more source
Add-on efgartigimod in myasthenic crisis: a promising treatment option. [PDF]
Shi F +11 more
europepmc +1 more source
Comprehensive analysis reveals the molecular heterogeneity and the differences in prognosis and immunotherapy sensitivity in hypermutated colorectal cancer. [PDF]
Bai G, Yang X, Xiao L, Xiong C.
europepmc +1 more source
Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin. [PDF]
Lv J, Li K, Zhou J, Yu R, Lu Q, Liu B.
europepmc +1 more source
Serum magnesium predictive value in hepatocellular carcinoma patients on first-line immunotherapy: a retrospective study. [PDF]
Cheng X, Wang W, Xue YN, Tang HL, Li D.
europepmc +1 more source
Adding Neoadjuvant Immunotherapy to Chemotherapy in Non-Metastatic Triple-Negative Breast Cancer: A Propensity-Matched Cohort Study from a Tertiary Cancer Center. [PDF]
Al-Masri M +5 more
europepmc +1 more source

